Scopolamine

CHEMBL569713 Phase 4 Approved Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

303.4 g/mol

LogP

0.9

Phase

4

Available as a skin patch worn behind the ear, this medication prevents the nausea and vomiting associated with motion sickness or post-surgical recovery by blocking nerve signals in the brain's balance and nausea centers. It is also occasionally used to reduce certain secretions in palliative care and respiratory conditions.

Molecular Weight

303.3500 g/mol

LogP

0.90

TPSA

62.30 Å²

Lipinski RO5

Pass

Therapeutic Areas

Alzheimer's Disease Asthma Bipolar Disorder Bladder Cancer Breast Cancer Cardiovascular Disease Chronic Obstructive Pulmonary Disease Chronic Pain Colorectal Cancer Epilepsy Generalized Anxiety Disorder Glaucoma Major Depressive Disorder Non-Small Cell Lung Cancer Obesity Ovarian Cancer Pain Management Prostate Cancer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Structure

SVG PNG

Cite this structure

Embed this structure

SMILES

CN1[C@@H]2C[C@@H](OC(=O)[C@H](CO)c3ccccc3)C[C@H]1[C@@H]1O[C@@H]12

InChI

InChI=1S/C17H21NO4/c1-18-13-7-11(8-14(18)16-15(13)22-16)21-17(20)12(9-19)10-5-3-2-4-6-10/h2-6,11-16,19H,7-9H2,1H3/t11-,12-,13-,14+,15-,16+/m1/s1

Molecular Formula

C17H21NO4

HBD / HBA

1 / 5

Rotatable Bonds

5

Heavy Atoms

22

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Frequently Asked Questions

Available as a skin patch worn behind the ear, this medication prevents the nausea and vomiting associated with motion sickness or post-surgical recovery by blocking nerve signals in the brain's balance and nausea centers. It is also occasionally used to reduce certain secretions in palliative care and respiratory conditions.

Yes, Scopolamine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL569713. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 3000322. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Looking for patient-friendly information?

Scopolamine on PillFYI

Structure

Quick Data

Formula: C17H21NO4
Synonyms: 7

External Links

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Medical Disclaimer

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.